Anthropic IPO (ANT) 6x Oversubscribed, Pricing Above Range

Anthropic's record Nasdaq IPO is about six times oversubscribed at $70-$78 a share, a $1.4 trillion valuation, making pricing above the range more likely.

Lead

What Happened to the Anthropic IPO Order Book?

The order book reached roughly six times coverage within days of the roadshow launch on November 10, when the company filed an amended registration statement setting the price range. Bankers told prospective buyers that existing backers would receive priority treatment, leaving some would-be buyers with smaller allocations than they requested. Details of the book could still change before pricing.

At the range's top, the valuation reaches about $1.405 trillion on a fully diluted basis. That compares with $965 billion in the company's May funding round and sits below the roughly $2 trillion level floated weeks earlier. Some investors had expected a higher figure, which is part of why demand at the marketed range is read as strong.

Why Is Pricing Above the Range More Likely?

Pricing above the range is more likely because a book several times covered gives underwriters room to raise the price without losing demand. Bankers typically build a book at a range set deliberately below where it can clear. When orders exceed supply by a multiple, the usual responses are to lift the range, price at or above the top, or both. The range can also move up during the roadshow, since it was set with a $1.4 trillion ceiling.

Several features of this deal point the same way:

• Scale of demand: Six times coverage on an offering of up to $64.4 billion implies several hundred billion dollars of orders.
• Allocation pressure: Priority for existing holders leaves less stock for new buyers, tightening the supply left for others.
• Growth: Annualized revenue run rate reached about $81 billion at the end of October, up from about $71 billion in late September.

Pricing at the top of $78 would value the company at the $1.4 trillion ceiling. Any move above the range would lift the implied valuation further.

How Does the AI Sell-Off Affect the Offering?

The sell-off has not dented demand so far, but it sets the backdrop for first-day trading. The Nasdaq fell 5.5% in the week before the range was set, erasing about $2.5 trillion in market value, as ai stocks sold off on regulatory concerns following the midterm elections. Weakness in large AI hardware names added to the pressure.

An IPO of this size also absorbs a large amount of institutional capital at once. Funds that buy ANT shares may need to trim other large technology holdings to do so. That supply effect is a separate risk from the demand picture, and it will become visible only once trading opens.

How to Buy IPO Shares Like Anthropic's?

Most individual investors cannot buy at the offer price, because allocations go first to institutions and existing shareholders. Some retail brokerages offer limited access to IPO allocations, but these are discretionary and typically small. Everyone else buys on the open market once trading begins, at whatever price the market sets. In a heavily oversubscribed deal, that price often opens above the offer price, so first-day pricing can differ widely from the range.

Priority for existing backers in this offering narrows retail access further.

Strategic Context

The listing is a test of how public markets value a company whose revenue is growing at a pace few firms of this size have matched. The company has also flagged in its filing that it "may imminently meet" an internal policy threshold for dramatically accelerated progress through AI-assisted research. It describes this as posing considerable safety risk if development speeds up sharply. That disclosure sits alongside the commercial case and is part of what buyers are weighing.

Valuation is the central question. A $1.4 trillion price places the company among the largest listed technology firms on day one, on revenue that is a fraction of theirs. Investors are pricing continued growth in enterprise adoption and heavy infrastructure spending to come.

Outlook

The next milestones are the pricing decision on November 18 and the Nasdaq debut on November 19. With the book about six times covered and existing holders prioritized, the balance of risks favors a final price at or above the $78 top of the range, though order details could still shift. After listing, attention turns to first-day trading, the supply of stock from existing holders, and whether the recent weakness in AI shares extends or reverses.